Characterization of PEG-iron oxide hydrogel nanocomposites for dual hyperthermia and paclitaxel delivery

Journal of Biomaterials Science, Polymer Edition

Volumn 24, Issue 9, 2013, Pages 1112-1126

  Meenach, Samantha A ^a,b   Shapiro, Jenna M ^a   Hilt, J Zach ^a   Anderson, Kimberly W ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b University of Kentucky   (United States)

Author keywords

hydrogel nanocomposites; hyperthermia; iron oxide nanoparticles; paclitaxel; poly(ethylene glycol) (PEG)

Indexed keywords

ALTERNATING MAGNETIC FIELD; CHEMOTHERAPEUTIC AGENTS; HYDROGEL NANOCOMPOSITES; HYDROGEL NETWORKS; HYPERTHERMIA; IRON OXIDE NANOPARTICLE; PACLITAXEL; PACLITAXEL DELIVERY;

CELL CULTURE; CHEMOTHERAPY; CYTOTOXICITY; HEATING; METAL NANOPARTICLES; NANOCOMPOSITES; POLYETHYLENE GLYCOLS; TISSUE;

HYDROGELS;

IRON OXIDE; IRON OXIDE NANOPARTICLE; MACROGOL; METHACRYLIC ACID; METHYL ETHER METHACRYLATE; NANOCOMPOSITE; PACLITAXEL; UNCLASSIFIED DRUG;

ARTICLE; BIOCOMPATIBILITY; CANCER CELL CULTURE; CONTROLLED STUDY; CROSS LINKING; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG POTENTIATION; DRUG RELEASE; HEATING; HUMAN; HUMAN CELL; HYDROGEL; HYPERTHERMIA; IN VITRO STUDY; MAGNETIC FIELD; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; DRUG CARRIERS; FERRIC COMPOUNDS; HOT TEMPERATURE; HUMANS; HYDROGEL; HYPERTHERMIA, INDUCED; NANOPARTICLES; PACLITAXEL; POLYETHYLENE GLYCOLS;

EID: 84878270598     PISSN: 09205063     EISSN: 15685624     Source Type: Journal    
DOI: 10.1080/09205063.2012.741321     Document Type: Article

References (29)

1. American Cancer Society [ACS]. Cancer facts and figures. Atlanta (GA): American Cancer Society; 2009.
2. Obara, K, Ishihara, M, Ozeki, Y, Ishizuka, T, Hayashi, T, Nakamura, S, Saito, Y, Yura, H, Matsui, T, Hattori, H, Takase, B, Ishihara, M, Kikuchi, M, and, Maehara, T. 2005. Controlled release of paclitaxel from photocrosslinked chitosan hydrogels and its subsequent effect on subcutaneous tumor growth in mice. J. Controlled Release., 110: 79-89. (Pubitemid 41713933)
3. Issels, RD. 2008. Hyperthermia adds to chemotherapy. Eur. J. Cancer., 44: 2546-2554.
4. Falk, MH, and, Issels, RD. 2001. Hyperthermia in oncology. Int. J. Hyperther., 17: 1-18. (Pubitemid 32058478)
5. Babincova, M, Sourivong, P, Leszczynska, D, and, Babinec, P. 2000. Blood-specific whole-body electromagnetic hyperthermia. Med. Hypothesis., 55: 459-460.
6. Hergt, R, Dutz, S, Muller, R, and, Zeisberger, M. 2006. Magnetic particle hyperthermia: nanoparticle magnetism and materials development for cancer therapy. J. Phys.: Condens. Matter., 18: S2919-S2934.
7. Wust, P, Hildebrandt, B, Sreenivasa, G, Rau, B, Gellerman, J, Riess, H, Felix, R, and, Schlag, PM. 2002. Hyperthermia in combined treatment of cancer. Oncology., 3: 487-497. (Pubitemid 34863670)
8. Michalakis, J, Georgatos, SD, de Bree, E, Polioudaki, H, Romanos, J, Georgoulias, V, Tsiftsis, DD, and, Theodoropolous, PA. 2007. Short-term exposure of cancer cells to micromolecular doses of pacilitaxel, with or without hyperthermia, induces long-term inhibition of cell proliferation and cell death in vitro. Ann. Surg. Oncol., 14: 1220-1228.
9. DiRamio, JA, Kisaalita, WS, Majetich, GF, and, Shimkus, JM. 2005. Poly(ethylene glycol) methacylate/dimethacrylate hydrogels for controlled release of hydrophobic drugs. Biotechnol. Prog., 21: 1281-1288. (Pubitemid 41099601)
10. Hilt, JZ, and, Byrne, ME. 2004. " Biomedical applications: tissue engineering, therapeutic devices, and diagnostic systems ". In Biomedical applications: tissue engineering, therapeutic devices, and diagnostic systems, Edited by: Schwarz, JA, Contescu, CI and Putyera, K. 247-262. New York, NY: Marcel Dekker.
11. Lin, H-H, and, Cheng, Y-L. 2001. In-situ thermoreversible gelation of block and star copolymers of poly(ethylene glycol) and poly(N- isopropylacrylamide) of varying architectures. Macromolecules, 34: 3710-3715. (Pubitemid 34216911)
12. Peppas, NA, Bures, P, Leobandung, W, and, Ichikawa, H. 2000. Hydrogels in pharmaceutical formulations. Eur. J. Pharm. Biopharm., 5: 27-46. (Pubitemid 30326687)
13. Peppas, NA, Hilt, JZ, Khademhosseini, A, and, Langer, R. 2006. Hydrogels in biology and medicine: from molecular principles to bionanotechnology. Adv. Mater., 18: 1345-1360. (Pubitemid 43898575)
14. Meenach, SA, Anderson, KW, and, Hilt, JZ. 2009. " Hydrogel nanocomposites: biomedical applications, biocompatibility and toxicity analysis ". In Safety of nanoparticles, Edited by: Webster, TJ. 131-157. New York, NY: Springer.
15. Meenach, SA, Anderson, AA, Suthar, M, Anderson, KW, and, Hilt, JZ. 2009. Biocompatibility analysis of magnetic hydrogel nanocomposites based on poly(N-isopropylacrylamide) and iron oxide. J. Biomed. Mater. Res. A., 91A: 903-909.
16. Meenach, SA, Hilt, JZ, and, Anderson, KW. 2009. Poly(ethylene glycol)-based magnetic hydrogel nanocomposites for hyperthermia cancer therapy. Acta Biomater., 6: 1039-1046.
17. Satarkar, NS, Zhang, W, Eitel, RE, and, Hilt, JZ. 2009. Magnetic hydrogel nanocomposites as remote controlled microfluidic valves. Lab-on-a-Chip., 9: 1773-1779.
18. Satarkar, NS, and, Hilt, JZ. 2008. Magnetic hydrogel nanocomposites for remote controlled pulsatile drug release. J. Controlled Release., 130: 246-251.
19. Hawkins, AM, Satarkar, NS, and, Hilt, JZ. 2009. Nanocomposite degradable hydrogels: demonstration of remote controlled degradation and drug release. Pharm. Res., 26: 667-673.
20. Babincova, M, Leszczynska, D, Sourivong, P, Cicmanec, P, and, Babinec, P. 2001. Superparamagnetic gel as a novel material for electromagnetically induced hyperthermia. J. Magn. Magn. Mater., 225: 109-112. (Pubitemid 32335282)
21. Bahadur, D, and, Giri, J. 2003. Biomaterials and magnetism. Sadhana., 28: 639-656.
22. Frimpong, RA, Fraser, S, and, Hilt, JZ. 2006. Synthesis and temperature response analysis of magnetic-hydrogel nanocomposites. J. Biomed. Mater. Res. Part A., 80A: 1-6.
23. Higuchi, T. 1961. Rate of release of medicaments from ointment bases containing drugs in suspension. J. Pharm. Sci., 50: 874-875.
24. Babincova, M, Altanerova, V, Altaner, C, Bergemann, C, and, Babinec, P. 2008. In vitro analysis of cisplatin functionalized magnetic nanoparticles in combined cancer chemotherapy and electromagnetic hyperthermia. IEEE Trans. Nanobiosci., 7: 15-19.
25. Ito, A, Fujioka, M, Yoshida, T, Wakamatsu, K, Ito, S, Yamashita, T, Jimbow, K, and, Honda, H. 2007. 4-S-Cysteaminylphenol-loaded magnetite cationic liposomes for combination therapy of hyperthermia with chemotherapy against malignant melanoma. Cancer Sci., 98: 424-430. (Pubitemid 46195616)
26. Meenach, SA, Anderson, KW, and, Hilt, JZ. 2010. Synthesis and characterization of thermoresponsive poly(ethylene glycol)-based hydrogels and their magnetic nanocomposites. J. Polym. Sci. Part A: Polym. Chem., 48: 3229-3235.
27. Shen, H, Hu, D, Du, J, Wang, X, Liu, Y, Wang, Y, Wei, J-m, Ma, D, Wang, P, and, Li, L. 2008. Paclitaxel-octreotide conjugates in tumor growth inhibition of A549 human non-small cell lung cancer xenografted into nude mice. Eur. J. Pharmacol., 601: 23-29.
28. Hildebrandt, B, Wust, P, Ahlers, O, Dieing, A, Sreenivasa, G, Kerner, T, Felix, R, and, Riess, H. 2002. The cellular and molecular basis of hyperthermia. Crit. Rev. Oncol. Hemat., 43: 33-56. (Pubitemid 34722786)
29. Nakao, K, Otsuki, Y, Akao, Y, Ito, Y, Marukawa, O, Tachibana, S, Kawakami, M, and, Sasaki, S. 2000. The synergistic effects of hyperthermia and anticancer drugs on induction of apoptosis. Med. Electron Microsc., 33: 44-50.